These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 4258297)

  • 61. The effect of muscle relaxants on cricothyroid muscle: a report of three cases.
    Moorthy SS; Reddy RV; Dunfield JA; Radpour S; Dierdorf SF
    Anesth Analg; 1996 Mar; 82(3):657-60. PubMed ID: 8623977
    [No Abstract]   [Full Text] [Related]  

  • 62. [Pharmacodynamic evaluation of a new synthetic curare-like agent: acetylenic-gallamine].
    Cloutier G; Goyer GR; Bolduc R; Salvador RL
    Arch Int Pharmacodyn Ther; 1970 Mar; 184(1):75-92. PubMed ID: 4247340
    [No Abstract]   [Full Text] [Related]  

  • 63. [Potential of succinylcholine-induced neuromuscular blockade by nitrous oxide].
    Tsuchiya A
    Masui; 1995 Dec; 44(12):1608-13. PubMed ID: 8583653
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Presynaptic aspects of neuromuscular transmission and block.
    Foldes FF
    Anaesthesist; 1971 Jan; 20(1):6-19. PubMed ID: 4322998
    [No Abstract]   [Full Text] [Related]  

  • 65. [The neuromuscular junction and mechanism of action of curariform drugs].
    Kienlen J
    Ann Fr Anesth Reanim; 1984; 3(2):116-28. PubMed ID: 6231869
    [No Abstract]   [Full Text] [Related]  

  • 66. [Recurarization after use of succinylcholine (listenone)].
    Khmelevskiĭ IaM; Sloventantor VIu
    Vestn Akad Med Nauk SSSR; 1974; (7):69-79. PubMed ID: 4280218
    [No Abstract]   [Full Text] [Related]  

  • 67. [Study of muscle relaxants using evoked electromyography. 4. Consideration on alteration of the recovery curve and action point of muscle relaxants by atropine, acetylcholine and edrophonium].
    Suzuki H; Nakagawa H; Kanayama T; Yazaki S
    Masui; 1971 Oct; 20(11):1049-58. PubMed ID: 4257582
    [No Abstract]   [Full Text] [Related]  

  • 68. [Relationship between the effect of proserine on the action of myorelaxants and their proper anticholinesterase activity].
    Danilov AF
    Eksp Khir Anesteziol; 1969; 14(1):59-64. PubMed ID: 4244999
    [No Abstract]   [Full Text] [Related]  

  • 69. Recovery from neuromuscular blockade during single shock and tetanic nerve stimulation in cats.
    Hughes R
    Br J Anaesth; 1970 Jul; 42(7):564-72. PubMed ID: 4247669
    [No Abstract]   [Full Text] [Related]  

  • 70. Effects of succinylcholine on the recovery of block produced by mivacurium in rats.
    Kanyamibwa D; Tsaousi G; Karakoulas K; Thomareis O; Parlapani A; Makedou AH; Giala M
    Methods Find Exp Clin Pharmacol; 2008 Apr; 30(3):187-91. PubMed ID: 18597002
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pancuronium bromide and other steroidal neuromuscular blocking agents containing acetylcholine fragments.
    Buckett WR; Hewett CL; Savage DS
    J Med Chem; 1973 Oct; 16(10):1116-24. PubMed ID: 4356139
    [No Abstract]   [Full Text] [Related]  

  • 72. [Changes in the reactivity of the anterior tibial muscle in cats following action of some piperazine derivatives].
    Angelov A; Sikolova S
    Eksp Med Morfol; 1974; 13(1):45-50. PubMed ID: 4365043
    [No Abstract]   [Full Text] [Related]  

  • 73. Effects of halogenoacetylcholines on the neuromuscular junction.
    Chiou CY
    Eur J Pharmacol; 1971; 13(3):367-73. PubMed ID: 5577499
    [No Abstract]   [Full Text] [Related]  

  • 74. The effects of three short-acting neuromuscular blocking agents on fast- and slow-contracting muscles of the cat.
    Marshall IG
    Eur J Pharmacol; 1973 Mar; 21(3):299-304. PubMed ID: 4267689
    [No Abstract]   [Full Text] [Related]  

  • 75. Ion exchange processes at the neuromuscular junction of voluntary muscle.
    Taylor DB; Steinborn J; Lu TC
    J Pharmacol Exp Ther; 1970 Oct; 175(1):213-27. PubMed ID: 5471448
    [No Abstract]   [Full Text] [Related]  

  • 76. The effect of ketamine upon depolarizing and non-depolarizing neuromuscular blockade in rabbit.
    Bogdan LG; Glisson SN; El-Etr AA
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 285(3):223-31. PubMed ID: 4156582
    [No Abstract]   [Full Text] [Related]  

  • 77. Monitoring of neuromuscular function in the clinical setting.
    Kelly D; Brull SJ
    Yale J Biol Med; 1993; 66(5):473-89. PubMed ID: 7825349
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Effect of various drugs on metabolism of skeletal muscles. 3. Effect of cholinergic, cholinesterase inhibitor and neuromuscular blocking agents on oxygen consumption of the skeletal musscles].
    Morikawa M
    Nihon Yakurigaku Zasshi; 1973 Mar; 69(2):335-41. PubMed ID: 4807884
    [No Abstract]   [Full Text] [Related]  

  • 79. Neuromuscular transmission and its pharmacological blockade. Part 2: Pharmacology of neuromuscular blocking agents.
    Booij LH
    Pharm World Sci; 1997 Feb; 19(1):13-34. PubMed ID: 9089750
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Suxamethonium--a review. II. Neuromuscular blocking properties.
    Gibb DB
    Anaesth Intensive Care; 1973 Feb; 1(3):183-201. PubMed ID: 4271665
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.